REFERENCES
- Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–2090. doi:https://doi.org/10.1016/j.ophtha.2014.05.013.
- Actis AG, Versino E, Brogliatti B, Rolle T. Risk factors for Primary Open Angle Glaucoma (POAG) Progression: a study ruled in Torino. Open Ophthalmol J. 2016;10:129–139. doi:https://doi.org/10.2174/1874364101610010129.
- Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol. 2008;53:S3–10. doi:https://doi.org/10.1016/j.survophthal.2008.08.006.
- Zhao D, Cho J, Kim MH, Friedman DS, Guallar E. Diabetes, fasting glucose, and the risk of glaucoma: a meta-analysis. Ophthalmology. 2015;122:72–78. doi:https://doi.org/10.1016/j.ophtha.2014.07.051.
- Salowe R, Salinas J, Farbman NH, et al. Primary open-angle glaucoma in individuals of African Descent: a review of risk factors. J Clin Exp Ophthalmol. 2015;6:450. doi:https://doi.org/10.4172/2155-9570.1000450.
- Tatham AJ, Medeiros FA, Zangwill LM, Weinreb RN. Strategies to improve early diagnosis in glaucoma. Prog Brain Res. 2015;221:103–133.
- Conlon R, Saheb H, Ahmed IIK. Glaucoma treatment trends: a review. Can J Ophthalmol. 2017;40(1):114–124. doi:https://doi.org/10.1016/j.jcjo.2016.07.013.
- Quaranta L, Riva I, Gerardi C, Oddone F, Floriano I, Konstas AGP. Quality of life in glaucoma: a review of the literature. Adv Ther. 2016;33(6):959–981. doi:https://doi.org/10.1007/s12325-016-0333-6.
- Enoch J, Jones L, Taylor DJ, et al. How do different lighting conditions affect the vision and quality of life of people with glaucoma? A systematic review. Eye. 2020;34:138–154. doi:https://doi.org/10.1038/s41433-019-0679-5.
- Agorastos A, Skevas C, Matthaei M, et al. Depression, anxiety, and disturbed sleep in glaucoma. J Neuropsychiatry Clin Neurosci. 2013;25:205–213. doi:https://doi.org/10.1176/appi.neuropsych.12020030.
- Eramudugolla R, Wood J, Anstey KJ. Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adults. Front Aging Neurosci. 2013;5:56. doi:https://doi.org/10.3389/fnagi.2013.00056.
- McCusker S, Koola MM. Association of ophthalmologic disorders and depression in the elderly: a review of the literature. Prim Care Companion CNS Disord. 2015;17(4). doi:https://doi.org/10.4088/PCC.14r01731.
- Rovner BW, Casten RJ, Hegel MT, et al. Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial. Ophthalmology. 2014;121:2204–2211. doi:https://doi.org/10.1016/j.ophtha.2014.05.002.
- Skalicky S, Goldberg I. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the geriatric depression scale-15, assessment of function related to vision, and the glaucoma quality of life-15. J Glaucoma. 2008;17:546–551. doi:https://doi.org/10.1097/IJG.0b013e318163bdd1.
- Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10:e1001547. doi:https://doi.org/10.1371/journal.pmed.1001547.
- Â R, Ribeiro JP, Von Doellinger O. Depression and psychodynamic psychotherapy. Braz J Psychiatry. 2018;40:105–109. doi:https://doi.org/10.1590/1516-4446-2016-2107.
- Agorastos A, Huber CG. The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential. J Pineal Res. 2011;50:1–7. doi:https://doi.org/10.1111/j.1600-079X.2010.00816.x.
- Chen YY, Lai YJ, Wang JP, et al. The association between glaucoma and risk of depression: a nationwide population-based cohort study. BMC Ophthalmol. 2018;18:146. doi:https://doi.org/10.1186/s12886-018-0811-5.
- Diniz-Filho A, Abe RY, Cho HJ, Baig S, Gracitelli CPB, Medeiros FA. Fast visual field progression is associated with depressive symptoms in patients with glaucoma. Ophthalmology. 2016;123(4):754–759. doi:https://doi.org/10.1016/j.ophtha.2015.12.014.
- Musch DC, Niziol LM, Janz NK, Gillespie BW. Trends in and predictors of depression among participants in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol. 2019;197:128–135. doi:https://doi.org/10.1016/j.ajo.2018.09.015.
- Rezapour J, Nickels S, Schuster AK, et al. Prevalence of depression and anxiety among participants with glaucoma in a population-based cohort study: the gutenberg health study. BMC Ophthalmol. 2018;18:157. doi:https://doi.org/10.1186/s12886-018-0831-1.
- Zhang X, Olson DJ, Le P, Lin FC, Fleischman D, Davis RM. The association between glaucoma, anxiety, and depression in a large population. Am J Ophthalmol. 2017;183:37–41. doi:https://doi.org/10.1016/j.ajo.2017.07.021.
- Bali SJ, Parmar T, Arora V, Ichhpujani P, Sagar R, Dada T. Evaluation of major depressive disorder in patients receiving chronic treatment with topical timolol. Ophthalmologica. 2011;226:157–160. doi:https://doi.org/10.1159/000328585.
- Chen VC, Ng MH, Chiu WC, et al. Effects of selective serotonin reuptake inhibitors on glaucoma: a nationwide population-based study. PLoS One. 2017;12:e0173005. doi:https://doi.org/10.1371/journal.pone.0173005.
- Cumurcu T, Cumurcu BE, Celikel FC, Etikan I. Depression and anxiety in patients with pseudoexfoliative glaucoma. Gen Hosp Psychiatry. 2006;28:509–515. doi:https://doi.org/10.1016/j.genhosppsych.2006.09.004.
- Kong X, Yan M, Sun X, Anxiety XZ. Depression are more prevalent in primary angle closure glaucoma than in primary open-angle glaucoma. J Glaucoma. 2015;24:e57–63. doi:https://doi.org/10.1097/IJG.0000000000000025.
- Mabuchi F, Yoshimura K, Kashiwagi K, et al. High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma. 2008;17(7):552–557. doi:https://doi.org/10.1097/IJG.0b013e31816299d4.
- Su CC, Chen JY, Wang TH, Huang JY, Yang CM, Wang IJ. Risk factors for depressive symptoms in glaucoma patients: a nationwide case-control study. Graefes Arch Clin Exp Ophthalmol. 2015;253:1319–1325. doi:https://doi.org/10.1007/s00417-015-3032-0.
- Tastan S, Iyigun E, Bayer A, Acikel C. Anxiety, depression, and quality of life in Turkish patients with glaucoma. Psychol Rep. 2010;106:343–357. doi:https://doi.org/10.2466/pr0.106.2.343-357.
- Wilson MR, Coleman AL, Yu F, Fong Sasaki I, Bing EG, Kim MH. Depression in patients with glaucoma as measured by self-report surveys. Ophthalmology. 2002;109:1018–1022. doi:https://doi.org/10.1016/S0161-6420(02)00993-4.
- Jonas JB, Wei WB, Xu L, Rietschel M, Streit F, Wang YX. Self-rated depression and eye diseases: the Beijing Eye Study. PLoS One. 2018;13:e0202132. doi:https://doi.org/10.1371/journal.pone.0202132.
- Jung KI, Park CK. Mental health status and quality of life in undiagnosed glaucoma patients: a nationwide population-based study. Medicine (Baltimore). 2016;95(19):e3523. doi:https://doi.org/10.1097/MD.0000000000003523.
- Lim NC, Fan CH, Yong MK, Wong EP, Yip LW. Assessment of depression, anxiety, and quality of life in singaporean patients with glaucoma. J Glaucoma. 2016;25:605–612. doi:https://doi.org/10.1097/IJG.0000000000000393.
- Mabuchi F, Yoshimura K, Kashiwagi K, et al. Risk factors for anxiety and depression in patients with glaucoma. Br J Ophthalmol. 2012;96:821–825.
- Ayaki M, Shiba D, Negishi K, Tsubota K. Depressed visual field and mood are associated with sleep disorder in glaucoma patients. Sci Rep. 2016;6:25699. doi:https://doi.org/10.1038/srep25699.
- Ra S, Ayaki M, Yuki K, Tsubota K, Negishi K. Dry eye, sleep quality, and mood status in glaucoma patients receiving prostaglandin monotherapy were comparable with those in non-glaucoma subjects. PLoS One. 2008;17(11):e0188534. doi:https://doi.org/10.1371/journal.pone.0188534.
- Wang SY, Singh K, Lin SC. Prevalence and predictors of depression among participants with glaucoma in a nationally representative population sample. Am J Ophthalmol. 2012;154:436–444. doi:https://doi.org/10.1016/j.ajo.2012.03.039.
- Weiss GA, Goldich Y, Bartov E, Burgansky-Eliash Z. Compliance with eye care in glaucoma patients with comorbid depression. Isr Med Assoc J. 2011;13:730–734.
- Yaşar E, Yıldırım N, Pseudoexfoliation Syndrome AE, Pseudoexfoliation Syndrome and Antidepressant Drug Use. Turk J Ophthalmol. 2019;49:1–5. doi:https://doi.org/10.4274/tjo.galenos.2018.06887.
- Zhang D, Fan Z, Gao X, et al. Illness uncertainty, anxiety and depression in Chinese patients with glaucoma or cataract. Sci Rep. 2018;8:11671. doi:https://doi.org/10.1038/s41598-018-29489-1.
- Thau AJ, Rohn MCH, Biron ME, et al. Depression and quality of life in a community-based glaucoma-screening project. Can J Ophthalmol. 2018;53:354–360. doi:https://doi.org/10.1016/j.jcjo.2017.10.009.
- Kong XM, Zhu WQ, Hong JX, Sun XH. Is glaucoma comprehension associated with psychological disturbance and vision-related quality of life for patients with glaucoma? A cross-sectional study. BMJ Open. 2014;4(5):e004632. doi:https://doi.org/10.1136/bmjopen-2013-004632.
- Wu N, Kong X, Gao J, Sun X. Vision-related quality of life in glaucoma patients and its correlations with psychological disturbances and visual function indices. J Glaucoma. 2019;28:207–215. doi:https://doi.org/10.1097/IJG.0000000000001178.
- Gamiochipi-Arjona JE, Azses-Halabe Y, Tolosa-Tort P, et al. Depression and Medical Treatment Adherence in Mexican Patients with Glaucoma. Glaucoma J in press. doi:https://doi.org/10.1097/IJG.0000000000001739
- Onwubiko SN, Nwachukwu NZ, Muomah RC, Okoloagu NM, Ngwegu OM, Nwachukwu DC. Factors associated with depression and anxiety among glaucoma patients in a tertiary hospital South-East Nigeria. Niger J Clin Pract. 2020;23(3):315–321. doi:https://doi.org/10.4103/njcp.njcp_140_19.
- Abe RY, Silva LNP, Silva DM, Vasconcellos JPC, Costa VP. Prevalence of depressive and anxiety disorders in patients with glaucoma: a cross-sectional study. Arq Bras Oftalmol. 2021;84:31–36. doi:https://doi.org/10.5935/0004-2749.20210006.
- Shin DY, Jung KI, Park HYL, Park CK. The effect of anxiety and depression on progression of glaucoma. Sci Rep. 2021;11:1769. doi:https://doi.org/10.1038/s41598-021-81512-0.
- Wang HY, Tseng PT, Stubbs B, et al. The risk of glaucoma and serotonergic antidepressants: a systematic review and meta-analysis. J Affect Disord. 2018;241:63–70. doi:https://doi.org/10.1016/j.jad.2018.07.079.